microfil Search Results


95
World Precision Instruments non metallic syringe needle
Non Metallic Syringe Needle, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pm42032713-51-1-5?v=World+Precision+Instruments
Average 95 stars, based on 1 article reviews
non metallic syringe needle - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
World Precision Instruments microfils
Microfils, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc03655719-210-54-57?v=World+Precision+Instruments
Average 93 stars, based on 1 article reviews
microfils - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
SCHOTT alkyne-functionalized microfillers schott
Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized <t>microfillers</t> (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.
Alkyne Functionalized Microfillers Schott, supplied by SCHOTT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc05889148-171-48-49?v=SCHOTT
Average 90 stars, based on 1 article reviews
alkyne-functionalized microfillers schott - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc intravascular contrast microfil
Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized <t>microfillers</t> (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.
Intravascular Contrast Microfil, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/10__1161_slash_jaha__117__006207-96-7-9?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
intravascular contrast microfil - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc microfil mv-122
Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized <t>microfillers</t> (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.
Microfil Mv 122, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc11948236-56-16-3?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
microfil mv-122 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flowtech Corporation microfil
Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized <t>microfillers</t> (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.
Microfil, supplied by Flowtech Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc03976676-66-0-3?v=Flowtech+Corporation
Average 90 stars, based on 1 article reviews
microfil - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc microfil
Comparison of previous anatomical studies and this study.
Microfil, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc04664386-84-7-9?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
microfil - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flowtech Corporation microfil mv-112 (white)
Comparison of previous anatomical studies and this study.
Microfil Mv 112 (White), supplied by Flowtech Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/10__1161_slash_atvbaha__108__180349-342-13-16?v=Flowtech+Corporation
Average 90 stars, based on 1 article reviews
microfil mv-112 (white) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc microfil contrast agent
Comparison of previous anatomical studies and this study.
Microfil Contrast Agent, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/bio_rxiv__535328-168-24-28?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
microfil contrast agent - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc microfil compound
Growth of blood vessels into the infarcted myocardium, LV function, and cardiac survival after permanent LAD occlusion require endothelial Itgb1 expression . ( A–D, H–K ) Representative bright-field images of <t>Microfil-perfused</t> mouse hearts to visualize the coronary vasculature 14 days after permanent LAD occlusion. Mice were treated with (A, B) ctrl-AB and (C, D) β1-B-AB. Alternatively, tamoxifen-induced (H, I) control and (J, K) Itgb1 iECKO mice were used. ( E–G, L–N ) Quantification of LV myocardial function represented by (E, L) the end-diastolic volume, (F, M) the end-systolic volume, and (G, N) the LV ejection fraction at 0, 1, 7, and 14 days after LAD occlusion in wild-type mice treated with (E–G) ctrl-AB versus β1-B-AB or in (L–N) control versus Itgb1 iECKO mice. Reported values are means ± SEM. (E–G) Ctrl-AB: n = 5; β1-B-AB: n = 5; (L–N) control: n = 7; Itgb1 iECKO n = 5. Statistical significance was determined using unpaired two-tailed Student's t -test. * p -Values: (N) 7 d = 0.01; 14 d = 0.03. ( O–R ) Representative bright-field images of an Itgb1 iECKO mouse heart with myocardial rupture as (O, P) overview or as (Q, R) transversal sections. Arrows indicate the rupture. In panels (Q) and (R), the LV and RV are labeled. ( S ) Quantification of survival in a Kaplan–Meier curve in control versus Itgb1 iECKO mice. Control 0 d: n = 10, 7 d: n = 8; Itgb1 iECKO 0 d: n = 8, 1 d: n = 7, and upon 4 d: n = 5. Of note, one Itgb1 iECKO mouse died after 0 d measurement of cardiac function, but before permanent LAD occlusion, and therefore was excluded from the Kaplan–Meier curve. Only mice which received a permanent LAD occlusion are shown. Statistical significance was determined using the log-rank (Mantel–Cox) test. LAD, left anterior descending artery; LV, left ventricular; SEM, standard error of mean.
Microfil Compound, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc08180378-73-16-18?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
microfil compound - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc liquid silicon rubber microfil
Growth of blood vessels into the infarcted myocardium, LV function, and cardiac survival after permanent LAD occlusion require endothelial Itgb1 expression . ( A–D, H–K ) Representative bright-field images of <t>Microfil-perfused</t> mouse hearts to visualize the coronary vasculature 14 days after permanent LAD occlusion. Mice were treated with (A, B) ctrl-AB and (C, D) β1-B-AB. Alternatively, tamoxifen-induced (H, I) control and (J, K) Itgb1 iECKO mice were used. ( E–G, L–N ) Quantification of LV myocardial function represented by (E, L) the end-diastolic volume, (F, M) the end-systolic volume, and (G, N) the LV ejection fraction at 0, 1, 7, and 14 days after LAD occlusion in wild-type mice treated with (E–G) ctrl-AB versus β1-B-AB or in (L–N) control versus Itgb1 iECKO mice. Reported values are means ± SEM. (E–G) Ctrl-AB: n = 5; β1-B-AB: n = 5; (L–N) control: n = 7; Itgb1 iECKO n = 5. Statistical significance was determined using unpaired two-tailed Student's t -test. * p -Values: (N) 7 d = 0.01; 14 d = 0.03. ( O–R ) Representative bright-field images of an Itgb1 iECKO mouse heart with myocardial rupture as (O, P) overview or as (Q, R) transversal sections. Arrows indicate the rupture. In panels (Q) and (R), the LV and RV are labeled. ( S ) Quantification of survival in a Kaplan–Meier curve in control versus Itgb1 iECKO mice. Control 0 d: n = 10, 7 d: n = 8; Itgb1 iECKO 0 d: n = 8, 1 d: n = 7, and upon 4 d: n = 5. Of note, one Itgb1 iECKO mouse died after 0 d measurement of cardiac function, but before permanent LAD occlusion, and therefore was excluded from the Kaplan–Meier curve. Only mice which received a permanent LAD occlusion are shown. Statistical significance was determined using the log-rank (Mantel–Cox) test. LAD, left anterior descending artery; LV, left ventricular; SEM, standard error of mean.
Liquid Silicon Rubber Microfil, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc04111842-105-33-37?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
liquid silicon rubber microfil - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Flow Tech Inc resin casting microfil red
Growth of blood vessels into the infarcted myocardium, LV function, and cardiac survival after permanent LAD occlusion require endothelial Itgb1 expression . ( A–D, H–K ) Representative bright-field images of <t>Microfil-perfused</t> mouse hearts to visualize the coronary vasculature 14 days after permanent LAD occlusion. Mice were treated with (A, B) ctrl-AB and (C, D) β1-B-AB. Alternatively, tamoxifen-induced (H, I) control and (J, K) Itgb1 iECKO mice were used. ( E–G, L–N ) Quantification of LV myocardial function represented by (E, L) the end-diastolic volume, (F, M) the end-systolic volume, and (G, N) the LV ejection fraction at 0, 1, 7, and 14 days after LAD occlusion in wild-type mice treated with (E–G) ctrl-AB versus β1-B-AB or in (L–N) control versus Itgb1 iECKO mice. Reported values are means ± SEM. (E–G) Ctrl-AB: n = 5; β1-B-AB: n = 5; (L–N) control: n = 7; Itgb1 iECKO n = 5. Statistical significance was determined using unpaired two-tailed Student's t -test. * p -Values: (N) 7 d = 0.01; 14 d = 0.03. ( O–R ) Representative bright-field images of an Itgb1 iECKO mouse heart with myocardial rupture as (O, P) overview or as (Q, R) transversal sections. Arrows indicate the rupture. In panels (Q) and (R), the LV and RV are labeled. ( S ) Quantification of survival in a Kaplan–Meier curve in control versus Itgb1 iECKO mice. Control 0 d: n = 10, 7 d: n = 8; Itgb1 iECKO 0 d: n = 8, 1 d: n = 7, and upon 4 d: n = 5. Of note, one Itgb1 iECKO mouse died after 0 d measurement of cardiac function, but before permanent LAD occlusion, and therefore was excluded from the Kaplan–Meier curve. Only mice which received a permanent LAD occlusion are shown. Statistical significance was determined using the log-rank (Mantel–Cox) test. LAD, left anterior descending artery; LV, left ventricular; SEM, standard error of mean.
Resin Casting Microfil Red, supplied by Flow Tech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfil/pmc05498000-332-7-11?v=Flow+Tech+Inc
Average 90 stars, based on 1 article reviews
resin casting microfil red - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized microfillers (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.

Journal: Dental materials : official publication of the Academy of Dental Materials

Article Title: Evaluation of Biofilm Formation on Novel Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC)-Based Resins for Dental Restoratives

doi: 10.1016/j.dental.2018.01.011

Figure Lengend Snippet: Evaluation of bioburden on novel CuAAC-based and BisGMA-TEGDMA-based composites using non-disruptive (A) and disruptive analyses (B). Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N3:alkyne), with 2 mole percentage of CuCl2[PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized microfillers (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs. Disruptive analysis (B) of CuAAC 60% composite discs and BisGMA-TEGDMA 60% composite discs also showed a significant reduction (p <0.05), having nearly a 2-log reduction in bioburden on CuAAC based composites.

Article Snippet: Nondisruptive luciferase analysis (A) of S. mutans firefly biofilm grown on CuAAC 60% composite discs (containing AZ-2 diazide, trialkyne (a mole ratio of 1:1 to N 3 :alkyne), with 2 mole percentage of CuCl 2 [PMDETA] per functionality, 2 mole percentage of CQ and 60-weight percentage of alkyne-functionalized microfillers (Schott, 0.4 µm)) and on BisGMA-TEGDMA 60% composite discs (n=12) (containing BisGMA-TEGDMA (70:30 weight ratio) with 2-weight percentage of CQ having 60-weight percentage of methacrylated microfillers (Schott, 0.4 µm)) indicated a statistically significant reduction (p >0.05) in luminescence, indicating a reduced bioburden on CuAAC composite discs.

Techniques: Bioburden Testing, Luciferase

Comparison of previous anatomical studies and this study.

Journal: PLoS ONE

Article Title: Intrahepatic Vascular Anatomy in Rats and Mice—Variations and Surgical Implications

doi: 10.1371/journal.pone.0141798

Figure Lengend Snippet: Comparison of previous anatomical studies and this study.

Article Snippet: Additional four portal veins were injected with Microfil ® (Flow Tech Inc., USA).

Techniques: Comparison, In Vivo, Ex Vivo, Dissection, Preserving, Functional Assay

Growth of blood vessels into the infarcted myocardium, LV function, and cardiac survival after permanent LAD occlusion require endothelial Itgb1 expression . ( A–D, H–K ) Representative bright-field images of Microfil-perfused mouse hearts to visualize the coronary vasculature 14 days after permanent LAD occlusion. Mice were treated with (A, B) ctrl-AB and (C, D) β1-B-AB. Alternatively, tamoxifen-induced (H, I) control and (J, K) Itgb1 iECKO mice were used. ( E–G, L–N ) Quantification of LV myocardial function represented by (E, L) the end-diastolic volume, (F, M) the end-systolic volume, and (G, N) the LV ejection fraction at 0, 1, 7, and 14 days after LAD occlusion in wild-type mice treated with (E–G) ctrl-AB versus β1-B-AB or in (L–N) control versus Itgb1 iECKO mice. Reported values are means ± SEM. (E–G) Ctrl-AB: n = 5; β1-B-AB: n = 5; (L–N) control: n = 7; Itgb1 iECKO n = 5. Statistical significance was determined using unpaired two-tailed Student's t -test. * p -Values: (N) 7 d = 0.01; 14 d = 0.03. ( O–R ) Representative bright-field images of an Itgb1 iECKO mouse heart with myocardial rupture as (O, P) overview or as (Q, R) transversal sections. Arrows indicate the rupture. In panels (Q) and (R), the LV and RV are labeled. ( S ) Quantification of survival in a Kaplan–Meier curve in control versus Itgb1 iECKO mice. Control 0 d: n = 10, 7 d: n = 8; Itgb1 iECKO 0 d: n = 8, 1 d: n = 7, and upon 4 d: n = 5. Of note, one Itgb1 iECKO mouse died after 0 d measurement of cardiac function, but before permanent LAD occlusion, and therefore was excluded from the Kaplan–Meier curve. Only mice which received a permanent LAD occlusion are shown. Statistical significance was determined using the log-rank (Mantel–Cox) test. LAD, left anterior descending artery; LV, left ventricular; SEM, standard error of mean.

Journal: Thrombosis and Haemostasis

Article Title: Endothelial β1 Integrin-Mediated Adaptation to Myocardial Ischemia

doi: 10.1055/s-0040-1721505

Figure Lengend Snippet: Growth of blood vessels into the infarcted myocardium, LV function, and cardiac survival after permanent LAD occlusion require endothelial Itgb1 expression . ( A–D, H–K ) Representative bright-field images of Microfil-perfused mouse hearts to visualize the coronary vasculature 14 days after permanent LAD occlusion. Mice were treated with (A, B) ctrl-AB and (C, D) β1-B-AB. Alternatively, tamoxifen-induced (H, I) control and (J, K) Itgb1 iECKO mice were used. ( E–G, L–N ) Quantification of LV myocardial function represented by (E, L) the end-diastolic volume, (F, M) the end-systolic volume, and (G, N) the LV ejection fraction at 0, 1, 7, and 14 days after LAD occlusion in wild-type mice treated with (E–G) ctrl-AB versus β1-B-AB or in (L–N) control versus Itgb1 iECKO mice. Reported values are means ± SEM. (E–G) Ctrl-AB: n = 5; β1-B-AB: n = 5; (L–N) control: n = 7; Itgb1 iECKO n = 5. Statistical significance was determined using unpaired two-tailed Student's t -test. * p -Values: (N) 7 d = 0.01; 14 d = 0.03. ( O–R ) Representative bright-field images of an Itgb1 iECKO mouse heart with myocardial rupture as (O, P) overview or as (Q, R) transversal sections. Arrows indicate the rupture. In panels (Q) and (R), the LV and RV are labeled. ( S ) Quantification of survival in a Kaplan–Meier curve in control versus Itgb1 iECKO mice. Control 0 d: n = 10, 7 d: n = 8; Itgb1 iECKO 0 d: n = 8, 1 d: n = 7, and upon 4 d: n = 5. Of note, one Itgb1 iECKO mouse died after 0 d measurement of cardiac function, but before permanent LAD occlusion, and therefore was excluded from the Kaplan–Meier curve. Only mice which received a permanent LAD occlusion are shown. Statistical significance was determined using the log-rank (Mantel–Cox) test. LAD, left anterior descending artery; LV, left ventricular; SEM, standard error of mean.

Article Snippet: To image the entire coronary vasculature, hearts were washed and retrograde-perfused via the thoracic aorta with Microfil compound (Flow Tech Inc.), previously described but modified.

Techniques: Expressing, Control, Two Tailed Test, Labeling